Sign in
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal
Journal article   Peer reviewed

The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal

Kelly H SKELTON, David A GUTMAN, K. V THRIVIKRAMAN, Charles B NEMEROFF and Michael J OWENS
Psychopharmacologia, Vol.192(3), pp.385-396
2007
PMID: 17297634

Abstract

Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Pharmacology. Drug treatments Biological and medical sciences Medical sciences Neuropharmacology

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.5 Neuroscience
1.5.420 Cortisol
Web Of Science research areas
Neurosciences
Pharmacology & Pharmacy
Psychiatry
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details